Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FeetSee Thermal Images Collection Protocol in Diabetes Patients

NCT: NCT07300163 · RECRUITING

NCT IDNCT07300163
StatusRECRUITING
Start Date2025-12-16
Completion2027-05-30
SponsorDiabetis JSC (INDUSTRY)
First posted
Last updated

Brief Summary

Diabetic foot ulcers (DFUs) are a major cause of morbidity, lower-extremity amputation and healthcare costs in people with diabetes. DFUs often develop without pain or warning symptoms because of diabetic peripheral neuropathy, so patients may not recognise early signs of tissue damage. Monitoring plantar foot skin temperature is a promising strategy to detect early "hot-spots" of inflammation that precede ulceration and could trigger timely preventive action. This prospective, single-group study will enrol adults with type 1 or type 2 diabetes, a history of plantar DFU that has been healed for at least 6 weeks, and evidence of diabetic peripheral neuropathy. Participants will be recruited from hospital clinics in the United Kingdom and Lithuania. After a baseline assessment (including medical history and neuropathy testing), each participant will receive the FeetSee system, consisting of a thermal camera attached to their own smartphone or tablet, a stand, and the FeetSee mobile application. Participants will be instructed to acquire thermal and optical images of both feet at home at least once per day for 6-9 months, or until a new DFU develops. Images will be uploaded securely to cloud storage, where the FeetSee algorithm will analyse temperature patterns, comparing mirrored regions of both feet to identify potential inflammatory "hot-spots" associated with DFU risk. Participants will continue to receive standard clinical care throughout the study. The primary objective is to generate a longitudinal foot temperature dataset in this high-risk population and use it to retrospectively test and refine the FeetSee algorithm for predicting DFU occurrence. The primary outcome is the incidence of new DFUs during follow-up. Secondary objectives are to assess the feasibility and acceptability of daily device use (recruitment, retention, adherence, user and healthcare-provider questionnaires) and to document any device-related or system-related safety issues.

Frequently Asked Questions

What is FeetSee Thermal Images Collection Protocol in Diabetes Patients?

FeetSee Thermal Images Collection Protocol in Diabetes Patients is a clinical trial registered under NCT07300163. Current status: RECRUITING.

What is the status of NCT07300163?

The current status of NCT07300163 (FeetSee Thermal Images Collection Protocol in Diabetes Patients) is: RECRUITING.

When did FeetSee Thermal Images Collection Protocol in Diabetes Patients start?

FeetSee Thermal Images Collection Protocol in Diabetes Patients started on 2025-12-16.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.